Skip to main content
All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for SICKLE CELL DISEASE ASSOCIATION OF AMERICA · national organization dedicated to supporting people living with sickle cell disease

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $20,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 8
  • HR 1796
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
  • S 735
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
  • S 721
    Sickle Cell Disease Comprehensive Care Act
  • HR 5178
    Sickle Cell Disease Comprehensive Care Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 8067
    Candis King Hope for Sickle Cell Families Act
  • HR 247
    Health Care Affordability Act of 2025
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
 Lobbying activity 4
Health Issues

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 1796/S. 735)

Medicare/Medicaid

Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease Implementation of H.R. 1, One Big Beautiful Bill Act Issues relating to medical listings of impairment for sickle cell disease for SSDI and SSI

Budget/Appropriations

Funding for federal sickle cell disease programs FY26 House and Senate Labor-HHS Appropriations bills FY27 House and Senate Labor-HHS Appropriations H.R. 8067, Candis King Hope for Sickle Cell Families Act

Insurance

Implementation of H.R. 1, One Big Beautiful Bill Act Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem